ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

China's CanSino reports 'positive' data from COVID mRNA booster test

Following the shots, adults had 27 times higher levels of virus-neutralizing antibodies

China's CanSino Biologics has been developing one of the country's first home-grown potential vaccines based on mRNA technology.   © Reuters

HONG KONG/LONDON (Reuters) -- China's CanSino Biologics Inc reported on Thursday "positive" interim data from its experimental COVID-19 mRNA booster vaccine in a mid-stage clinical trial, as the country races to tame a severe outbreak of infections.

Infections have spiraled since China abandoned its strict "zero COVID" policy last month after protests against tight restrictions placed on its citizens.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more